Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Fowler

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Haematologica|May 6, 2017
Tbet is a critical modulator of FoxP3 expression in autoimmune graft-<i>versus</i>-host diseaseShoba Amarnath, Arian Laurence, Nathaniel Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 7, 2010
The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejectionJacopo Mariotti, Justin Taylor, Paul R Massey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Cancer|December 31, 2009
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomaMichael R Bishop, Robert M Dean, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphomaRobert M Dean, Daniel H Fowler, Wyndham H Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantationNancy M Hardy, Frances Hakim, Seth M Steinberg, et al.
EMBO Molecular Medicine|March 17, 2022
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disordersMurtaza S Nagree, Tania C Felizardo, Mary L Faber, et al.
Transfusion|October 27, 2018
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independenceLinda M Griffith, Mark VanRaden, A John Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2Miriam E Mossoba, Jagdeep S Walia, Vanessa I Rasaiah, et al.
Cytotherapy|January 29, 2013
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsLuciano Castiello, Miriam Mossoba, Antonella Viterbo, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Haematologica|May 6, 2017
Tbet is a critical modulator of FoxP3 expression in autoimmune graft-<i>versus</i>-host diseaseShoba Amarnath, Arian Laurence, Nathaniel Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 7, 2010
The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejectionJacopo Mariotti, Justin Taylor, Paul R Massey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Cancer|December 31, 2009
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomaMichael R Bishop, Robert M Dean, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphomaRobert M Dean, Daniel H Fowler, Wyndham H Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantationNancy M Hardy, Frances Hakim, Seth M Steinberg, et al.
EMBO Molecular Medicine|March 17, 2022
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disordersMurtaza S Nagree, Tania C Felizardo, Mary L Faber, et al.
Transfusion|October 27, 2018
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independenceLinda M Griffith, Mark VanRaden, A John Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2Miriam E Mossoba, Jagdeep S Walia, Vanessa I Rasaiah, et al.
Cytotherapy|January 29, 2013
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsLuciano Castiello, Miriam Mossoba, Antonella Viterbo, et al.
Pageof 10